These results were consistent with that of recent reports that showed that basal-like cancers more frequently present abundant NDRG2 expression in association with CpG-hypomethylation, with is associated with aggressiveness and unfavorable outcomes in the basal-like subtype [48]. The gene discussed is NDRG2; the disease is cancer.